NCT01934036View on ClinicalTrials.gov

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
ObesityOverweight
Interventions
DIETARY_SUPPLEMENT

Obex

After concluded the two months of treatment, patients will be follow-up during three months without consumption of Obex.

DRUG

Placebo

After concluded the two months of treatment, patients will be follow-up during three months without consumption of the placebo.

Trial Locations (1)

28049

Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT01934036 - Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women | Biotech Hunter | Biotech Hunter